CONCENTRIX CORPORATION (CNXC): what the price assumes

boothcheck covers CONCENTRIX CORPORATION (CNXC) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CNXC

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 5.1% sits below it).

How unusual the bet is: n/a

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Asset, Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.4%); the inversion above states its own rate.

Per-Model Detail (n=9)

Solvency

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

• Concentrix runs customer-experience operations on contract for other companies across six verticals, the largest being technology and consumer electronics at 27% of revenue, and the whole book of about 10.0 billion dollars in revenue converted to a 5.2% trailing operating margin.
• The defining risk is written into its own risk factors: Some emerging technologies, including AI, GenAI, RPA, ML, VOC, IVR, and IoT, may cause an adverse shift in the way certain of our existing business operations are conducted, which is the company describing automation of the work it sells by the hour.
• Management trimmed fiscal 2026 revenue guidance on June 29, 2026 to a range of 9.93 to 10.03 billion dollars from 10.04 to 10.18 billion, so the next print is a test of whether the revised range holds.

Bull Case

Start with when the money is due, because for this equity that matters more than what it is worth today. The term loans run out to two dates: The maturity date of the New Term Loan Facility and the 3-Year DD Term Loan Facility is September 30, 2028. The maturity date of the 5-Year DD Term Loan Facility and the Revolving Credit Facility is April 11, 2030. Part of the cost is already nailed down. Cross-currency swap arrangements effectively converted the Delayed Draw Term Loans into synthetic fixed euro-based debt at weighted average interest rates of 3.43% for the three-year term and 3.69% for the five-year term. A borrower with no near-term wall and a chunk of its interest fixed in the low threes is not in a liquidity fight. It has time, and time is exactly what a turnaround needs.

What it does with that time is generate cash. Trailing free cash flow ran about 513 million dollars against a market value near 1.4 billion. That is the whole bull case in one comparison, and it is not an accounting artifact: the operating business earned 509 million dollars of operating profit over the same trailing window, and a services company with light capital needs converts most of that straight through. Gross margin held at 35.0% in fiscal year 2025 against 35.9% the year before, so the erosion at the gross line has been a matter of tenths, not a collapse.

The gap that matters is below the gross line, and it is a fixable gap rather than a structural one. EXLS earned a 15.2% trailing operating margin on 2.157 billion dollars of revenue, and BR earned 17.1% on 7.322 billion. Concentrix earned 5.2% on roughly twice EXLS's revenue base. Closing even part of that distance does not require winning a single new client; it requires the existing book to run at what the industry already demonstrates is achievable. Management says it is happening, describing "record iX Suite growth and strong AI adoption" as the driver of margin expansion and a record quarterly cash flow in the most recent period.

There is also demand underneath the aggregate that the headline revenue number hides. In the first quarter of fiscal 2026, Revenue in our retail, travel and e-commerce vertical increased by 11.2%, a vertical carrying a quarter of the total. A book that is shrinking in one place and growing double digits in another is a mix problem, and mix problems get solved by the passage of contracts rather than by reinvention. Management has raised guidance three times, reaffirmed once and initiated new guidance twice since 2024, which is not the pattern of a team that has lost the thread of its own business.

None of this makes the leverage disappear. A holder is buying the residual claim that sits behind the lenders, and that is a genuinely risky place to stand. It also sits on top of a business that is profitable at the operating line, cash-generative, and financed to the end of the decade. If operating profit is merely flat when those maturities arrive, the equity is worth considerably more than a market value of 1.4 billion implies.

Bear Case

The product being sold here is people answering other companies' customers, billed by the seat and the hour. That is the fact from which everything else in the bear case descends, and Concentrix does not dress it up. Its own risk factors state that Some emerging technologies, including AI, GenAI, RPA, ML, VOC, IVR, and IoT, may cause an adverse shift in the way certain of our existing business operations are conducted, and warn separately that If we do not employ new technologies, including agentic AI and GenAI, as quickly or efficiently as our competitors the consequences are material. It describes its market as highly competitive, highly fragmented, and subject to rapid change. Read those together and the uncomfortable version emerges: when a vendor's efficiency gains are passed to the client, "strong AI adoption" and shrinking billable volume are two descriptions of one event.

That is why cheap does not settle the question. The enterprise trades at roughly 13 times company-wide operating income, low enough that the price sits below what even a decline of five percent a year in operating profit would warrant, and in the lower half of the range its peers command. The catch is who owns that enterprise. About 4.4 billion dollars of net debt ranks ahead of a market value near 1.4 billion, so the great majority of the business belongs to lenders and the listed shares are the sliver left over. A sliver moves violently on small changes in the whole. That is not a valuation opinion; it is arithmetic on the capital structure.

The leverage is real by any measure. Net debt sits at 8.63 times operating profit, or 10.85 times after-tax operating profit, against liquid assets of about 255.6 million dollars. And the capital-return policy has run alongside borrowing rather than instead of it: in fiscal 2025 the company paid 89.6 million dollars of dividends and repurchased shares in the same year it took net borrowings of $465.6 million made on term loan facilities. Distributions and drawdowns in the same twelve months is a policy that assumes the operating outlook holds.

Then there is the distance between the two profit figures. Trailing operating profit of 509 million dollars became a trailing bottom-line loss of about 1.3 billion. What sits in between is interest on the borrowings, amortization of intangible assets created by acquisition, and writedowns of carrying value. The auditors singled out the goodwill assessment, whose inputs are future revenue growth, EBITDA margin projections and the discount rate, noting that These significant assumptions are forward looking and could be affected by future economic and market conditions and the performance of the Company's reporting unit. Book value comes to 44.38 dollars a share, and a large part of that book is goodwill and intangible assets created when the acquisitions closed rather than anything that could be sold separately. That is why the market declines to pay it.

Two smaller pressures are worth naming because they hit the same line. The largest vertical is going the wrong way: Revenue in our technology and consumer electronics vertical decreased by 3.4% in the first quarter of fiscal 2026, and that vertical is 27% of the total. And the currency tailwind is not permanent. Roughly 54% of our revenue is priced in U.S. dollars, with the balance in euros, pounds, yen and others; in fiscal 2025 gross profit was helped by a net favorable foreign currency impact of $64.8 million. A stronger dollar reverses that help at a point in the income statement where there is little cushion. Management already trimmed the fiscal 2026 revenue range on June 29, 2026. A cut of about one percent at the top sounds minor until it passes through this much debt.

Valuation

Two figures describe this business better than any multiple does. The enterprise is worth roughly 6.7 billion dollars. The listed equity is worth about 1.4 billion. Nearly everything interesting about the price follows from the distance between those two numbers.

Take the enterprise first. The market is paying about 13 times company-wide operating income, a multiple low enough that the price sits below what even a decline of five percent a year in operating profit would warrant. That is a bound rather than a forecast: it does not say growth is expected, it says the price does not require any. Against its sector the multiple sits in the lower half of the peer range. On the company's own recent record, the operating pace embedded here is unremarkable, which is why this reads as broadly consistent with plausible outcomes rather than a stretch.

The methods split along exactly the line the capital structure draws. The asset-value approaches, anchored on a book value of 44.38 dollars a share, land well above today’s level, as do the peer-multiple approaches. The earnings-power approach, which capitalizes the free cash flow the business actually produces and then accounts for what the lenders are owed first, lands below the price. That disagreement is not a flaw in either lens. It is what leverage does: the same operating business supports very different equity values depending on whether you credit the carrying value of acquired assets or the cash that survives debt service.

Peer comparison sharpens where the operating problem sits rather than where the balance sheet does. EXLS turned 2.157 billion dollars of revenue into a 15.2% trailing operating margin, MMS 5.318 billion into 11.0%, and BR 7.322 billion into 17.1%. Concentrix is the second largest of that group by revenue and, among those disclosing a figure, the second lowest by operating margin at 5.2%. Scale is evidently not the constraint. Whatever separates a five-percent margin from a fifteen-percent one in this industry is contract mix, delivery cost and pricing, all of which move slowly.

Solvency is where the description ends because it is what bounds everything else. Net debt of about 4.4 billion dollars sits against liquid assets near 255.6 million, at 8.63 times operating profit before tax and 10.85 times after tax. The share count has risen about 4% a year over the four years to May 2026, so per-share arithmetic has been working against holders even while the company paid dividends. The maturities, though, are 2028 and 2030. That timing is the single most consequential fact in the file: the question this price poses is not whether Concentrix can pay its bills next year, but what its operating profit looks like on the day those loans come due.

Catalysts

The most recent information event was the second-quarter fiscal 2026 report on June 29, 2026, and it cut both ways. Management described record iX Suite growth and strong AI adoption as driving margin expansion and a record quarterly cash flow, while revenue came in slightly under its own guidance. In the same release the company reduced its fiscal 2026 revenue guidance to a range of 9.93 to 10.03 billion dollars, down from 10.04 to 10.18 billion. For a business this levered, the revenue line is the one that transmits fastest to the equity, and a trimmed range is therefore a bigger event here than the same trim would be at an unlevered peer.

The market reaction ran through the sell side rather than the fundamentals. Several brokers reduced their price targets in the days after the print, and the surviving spread between the lowest and highest of them is unusually wide for a company this size. That dispersion is itself the signal: analysts are not disagreeing about the current quarter, they are disagreeing about whether generative AI expands the addressable work or eats it.

Two things are worth tracking into the next report. The first is the technology and consumer electronics vertical, the largest of the six, which was declining in the most recent quarter disclosed in the filings; the retail, travel and e-commerce vertical was growing double digits over the same period, and the mix between them decides the aggregate. The second is the leverage path toward the September 2028 term loan maturity. Each quarter of cash generation that goes to debt reduction rather than distributions shortens the distance the operating business has to travel before that date stops being a question.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• EXLS (EXLSERVICE HOLDINGS, INC.)
• FY2025 10-K: …offset by a foreign exchange gain, net of hedging of $3.7 million. Gross margin in Healthcare and Life Sciences remained flat during fiscal 2025, compared to fiscal 2024. The increase in cost of revenues in Banking, Capital Markets and Diversified Industries by $30.2 million for fiscal 2025 was primarily due to…
• FY2025 10-K: …from our existing clients by 7.5% and new clients by 0.8% during fiscal 2025, compared to fiscal 2024. Revenue growth in Healthcare and Life Sciences by 23.7% was driven by the expansion of business from our existing clients by 22.4% and new clients, including revenue from ITI Data, by 1.3% during fiscal 2025,…
• MMS (Maximus, Inc.)
• FY2025 10-K: …customer services, and advanced technologies for modernization. We support programs and deliver services in the United Kingdom, including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East. 62 Table of Contents Table 3.1:…
• FY2025 10-K: …changes to programs in anticipation of these changes. The nature, extent and timing of these changes is still uncertain. We anticipate operating margins for the U.S. Services Segment in fiscal year 2026 to range between 10% and 11%. 37 Table of Contents Outside the U.S. Segment Our Outside the U.S. Segment provides…
• TNET (TRINET GROUP, INC.)
• FY2025 10-K: …to estimate our beginning WSEs for the next period and, as a result, can be used as an indicator of our potential future revenue growth, business growth, and client retention. Total WSEs decreased 10% when compared to the same period in 2024, primarily due to declines in our Technology, Professional Services, and…
• FY2025 10-K: …mergers and acquisitions, changes in medical utilization and related costs, client business failure and liquidity issues, the effects of competition, pricing of our services, and client decisions to administer all or a portion of their HR needs in-house without using our services. Client attrition for any of the…
• AMTM (Amentum Holdings, Inc.)
• FY2025 10-K: …constantly competing for project awards based on pricing, schedule and the breadth and technical sophistication of our services. Some of our competitors have made or could make acquisitions of businesses or establish agreements among themselves or third parties, which could allow them to offer more competitive and…
• FY2025 10-K: &E capabilities and our customers' increasing focus on efficiency will enable us to compete effectively. Our ability to replicate modernization efforts across new end markets and various stages of the government lifecycle will expand our addressable market and enable growth in excess of our customers' underlying…
• BR (BROADRIDGE FINANCIAL SOLUTIONS, INC.)
• FY2025 10-K: …were on Broadridge's trading platforms in both the current and prior year periods. Position Growth and Internal Trade Growth are useful non-financial metrics for investors in understanding how management measures and evaluates Broadridge's ongoing operational performance within its Investor Communication Solutions…
• FY2025 10-K: …Revenues and Recurring revenue are useful metrics for investors in understanding how management measures and evaluates the Company's ongoing operational performance. See "Results of Operations" as well as Note 2, "Summary of Significant Accounting Policies" and Note 3, "Revenue Recognition" to our Consolidated…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.